Promethazine Hydrochloride Injection

Links shared publicly online about this topic.

  • 1,744
    total visits

Promethazine Hydrochloride Injection

fda.gov

Boxed Warning added to labeling, describing risks of severe tissue injury, including gangrene, following intravenous administration of promethazine.

View full resource at fda.gov

Tags: Motion Sickness Medication, Nausea and Vomiting Medication, Drug, FDA, Phenergan, Pentazine, Nursing Professions, Nurse

  • Share

Most Recently Shared on September 17, 2009 at 11:56 pm By:

Also Shared By:

Doxorubicin hydrochloride liposome injection

fda.gov — “News BurstView full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on February 21, 2012 at 6:38 pm By:

ACCCbuzz ACCCBuzz Health Organization

Today FDA announced major actions taken to bolster supply of Doxil & preservative-free formulations of methotrexate http://t.co/tBxlu57g

2 months ago...

Bulletin

ashp.org — “BulletinView full resource at ashp.org

  • View Related
  • Share

Most Recently Shared on December 22, 2011 at 6:58 am By:

HospiScript HospiScript Services Health Organization

December 21st Release- Hydromorphone Hydrochloride Low Potency Injection Shortage http://t.co/flrcFNeg

4 months ago...

FDA grants final approval for Mylan's Promethazine HCl Tablets

news-medical.net — “Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Promethazine Hydrochloride (HCl) Tablets USP, 12.5 mg, 25 mg and 50 mg. Promethazine HCl Tablets are used to relieve the symptoms of certain allergic reactions, such as perennial and seasonal allergic rhinitis.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on September 9, 2011 at 1:47 pm By:

NewsMedical News-Medical.Net Health News

FDA grants final approval for Mylan's Promethazine HCl Tablets: Mylan Inc. today announced that its subsidiary M... http://t.co/YeLBvqa

7 months ago...

APP Pharmaceuticals Announces Approval And Launch Of Clonidine Hydrochloride Injection

medicalnewstoday.com — “APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA)View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on July 12, 2011 at 7:05 am By:

mnt_drugapprov MNT Drug Approvals Health News

APP Pharmaceuticals Announces Approval And Launch Of Clonidine Hydrochloride Injection http://mnt.to/3Y8L #regulatory

9 months ago...

Promethazine hydrochloride and dextromethorphan hydrobromide side effect: Alcohol abuse (Alcoholism) by eHealthMe.com

ehealthme.com — “Real world drug outcomes: Alcohol abuse in Promethazine hydrochloride and dextromethorphan hydrobromide. Who have it, when it happens and how? Find it out from a study of Promethazine hydrochloride and dextromethorphan hydrobromide users.View full resource at ehealthme.com

  • View Related
  • Share

Most Recently Shared on July 9, 2011 at 5:19 pm By:

PeterBrownPsy Peter H Brown Psychologist and Doctor

Promethazine hydrochloride and dextromethorphan hydrobromide side ... http://bit.ly/p7cXFW

9 months ago...

Pfizer Injectables Adds Doxorubicin Hydrochloride Injection, USP To Its Portfolio Of Off-Patent Oncology Products

medicalnewstoday.com — “Pfizer Injectables, part of Pfizer Inc.'s (NYSE: PFE) Established Products Business Unit, announced the addition of doxorubicin hydrochloride injection, USP, to Pfizer Injectables' growing portfolView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 18, 2011 at 9:09 am By:

MedicalFeed MedicalFeed Health News Feed

Pfizer Injectables Adds Doxorubicin Hydrochloride Injection, USP To Its Portfolio Of Off… http://goo.gl/fb/tdfb8

10 months ago...

Non-Sterile Chemotherapy Injections Recalled - EmpowHER.com

empowher.com — “Read about a recall of chemotherapy drugs that were found to be unsanitary.View full resource at empowher.com

  • View Related
  • Share

Most Recently Shared on April 1, 2011 at 12:00 am By:

EmpowHER EmpowHER Health Site

Attn: APP Pharmaceuticals, Inc. is recalling five lots of the #chemotherapy injection Irinotecan Hydrochloride: http://ow.ly/4qCvW

1 year ago...

FDA Alert: Irinotecan Hydrochloride Injection: Recall - Fungal Microbial Contaminant

drugs.com — “FDA Alert: Irinotecan Hydrochloride Injection: Recall - Fungal Microbial ContaminantView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 29, 2011 at 1:45 am By:

drugscom Drugs.com Health Site

FDA Alert - Recall: Irinotecan Hydrochloride Injection - Fungal Microbial Contaminant - http://bit.ly/ePzpD2

1 year ago...

APP Pharmaceuticals Recalls Irinotecan Hydrochloride Injections

usrecallnews.com — “APP Pharmaceuticals, is re recalling five lots of Irinotecan Hydrochloride Injection, which is used for recurrent or progressive metastatic colorectal cancer.View full resource at usrecallnews.com

  • View Related
  • Share

Most Recently Shared on March 28, 2011 at 7:42 pm By:

usrecallnews usrecallnews Health News

APP Pharmaceuticals Recalls Irinotecan Hydrochloride Injections http://f.ast.ly/ssMYY

1 year ago...

FDA MedWatch - Irinotecan Hydrochloride Injection: Recall - Fungal Microbial Contaminant - Drugs.com MedNews

drugs.com — “AUDIENCE Oncology, Pharmacy, Risk Manager ISSUE APP Pharmaceuticals, Inc. issued a voluntary recall of five lots of Irinotecan Hydrochloride Injection due to thView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 28, 2011 at 5:06 pm By:

Drugs_Devices Drugs and Devices OW OW Health

FDA MedWatch - Irinotecan Hydrochloride Injection: Recall - Fungal Microbial Contaminant: AUDIENCE: Oncolo... http://bit.ly/fhbqSE #drug

1 year ago...

APP recalls five lots of colorectal cancer drug | HemOncToday

hemonctoday.com — “Five lots of irinotecan hydrochloride injection were voluntarily recalled by manufacturer APP Pharmaceuticals, Inc. as a precautionary measurView full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on March 28, 2011 at 3:19 pm By:

HemOncToday HemOnc Today Health News and Oncology

APP recalls five lots of colorectal cancer drug http://bit.ly/i3EPtW

1 year ago...

APP Pharmaceuticals Issues A Nationwide Voluntary Recall Of Irinotecan Hydrochloride Injection

medicalnewstoday.com — “APP Pharmaceuticals, Inc., (APP) announced that it has issued a voluntary recall of five lots of Irinotecan Hydrochloride Injection, which is used for recurrent or progressive metastatic colorectaView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 28, 2011 at 9:05 am By:

mnt_colorectal MNT Colorectal Canc Health News

APP Pharmaceuticals Issues A Nationwide Voluntary Recall Of Irinotecan Hydrochloride Injection http://mnt.to/3SNx #colorectalcancer

1 year ago...

Eisai Marks Fully-fledged Entry into Japanese Oncology Market with Launch of Anticancer Agent Treakisym Injection 100 MG - Drugs.com MedNews

drugs.com — “TOKYO, Dec 10, 2010 - (JCN Newswire) - Eisai Co., Ltd. today launched the anticancer agent Treakisym Injection 100 mg (bendamustine hydrochloride) in Japan as aView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on December 10, 2010 at 3:13 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Eisai Marks Fully-fledged Entry into Japanese Oncology Market with Launch of Anticancer Agent Treakisym In... http://bit.ly/f6g2Dc #drug

1 year ago...

Sagent launches chemotherapy agent topotecan hydrochloride for injection

news-medical.net — “Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced U.S. FDA approval and launch of its topotecan hydrochloride for injection, a chemotherapy agent, in conjunction with the innovator's patent expiry. Sagent's topotecan is available in 4 mg single-dose latex-free vials.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on December 3, 2010 at 9:10 am By:

Oncology_News News-Medical.Net Health News and Oncology

Oncology News: Sagent launches chemotherapy agent topotecan hydrochloride for injection: Sagent Pharmaceuticals,... http://bit.ly/hpKyDG

1 year ago...

Astellas suspends patient enrollment from ACT 5 study of KYNAPID

news-medical.net — “Cardiome Pharma Corp. today announced that its co-development partner, Astellas Pharma US., Inc., has suspended patient enrollment in the ACT 5 study of KYNAPIDTM (vernakalant hydrochloride) Injection following a single unexpected serious adverse event of cardiogenic shock experienced by a patient with atrial fibrillation who received KYNAPID.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on October 22, 2010 at 9:39 am By:

NewsMedical News-Medical.Net Health News

Astellas suspends patient enrollment from ACT 5 study of KYNAPID: Cardiome Pharma Corp. today announced that its c... http://bit.ly/afLowq

1 year ago...

Advertisement